News

MSCI Reports Impressive Revenue Growth and Strong Quarter Performance

MSCI Reports Impressive Revenue Growth and Strong Quarter Performance

MSCI Posts Strong Financial Results

MSCI Inc. (NYSE: MSCI) has revealed its most recent financial performance, showcasing a revenue increase of 9.5% year-over-year amounting to a total revenue of $793.4 million. Despite slightly missing the analyst consensus estimate of $794.8 million, adjusted earnings per share (EPS) of $4.47 exceeded expectations.

Growth in Recurring Revenues

The annualized value of recurring revenues, also known as the total run rate, rose by 10.1%, reaching $3.19 billion. This growth reflects a healthy organic recurring subscription run rate increase of 7.4%. Customer retention remains robust, with an impressive rate of 94.7%, showing only a slight dip from the previous year's figure of 94.2%.

Positive Quarterly Figures

For the third quarter, the recurring subscription revenue exhibited a 7.9% increase, while asset-based fees ascended significantly by 17.1%. These metrics confirm strong consumer confidence in MSCI's product offerings.

Segment Breakdown

When analyzing specific segments, MSCI's Index operating revenues surged by 11.4% to $451.2 million. This surge can be attributed to increased recurring subscription revenues as well as asset-based fees. Additionally, Analytics operating revenues climbed by 5.7% to $182.2 million, showing a solid rise in recurring subscription revenues stemming from Equity and Multi-Asset Class Analytics products.

Sustainability and Cash Flow Insights

MSCI has transitioned into the Sustainability and Climate arena, with operating revenues in this segment reaching $90.1 million, a notable 7.7% year-over-year increase. The All Other private assets category saw its revenues improve by 9.7% to $70.0 million, propelled by strong growth in recurring subscriptions related to Private Capital Solutions.

Financially, MSCI reported an operating margin improvement from 55.4% to 56.4%. The adjusted EBITDA margin also showed slight growth from 62.2% to 62.3%. Throughout this quarter, the company generated a remarkable $423.3 million in free cash flow, maintaining a cash and equivalents position of $400.1 million.

Significant Capital Moves

In terms of capital allocation, MSCI executed share repurchases totaling $1.25 billion. On October 25, the Board authorized an expansive stock repurchase program allowing for an additional $3.0 billion in repurchases of common stock.

Future Projections and Insights

The company declared an upcoming cash dividend of $1.80 per share for the fourth quarter, rewarding shareholders and emphasizing its stable growth strategy. MSCI Chairman and CEO Henry A. Fernandez remarked on delivering remarkable financial and sales results, citing record high recurring sales in both Index and Analytics sectors. An impressive $6.4 trillion in assets under management that are linked to MSCI's indexes has notably spurred asset-based fee growth.

FY25 Projections

On the outlook for fiscal year 2025, MSCI has slightly increased its operating expenses forecast to between $1.415 billion and $1.445 billion, alongside capital expenditures forecasted at $120 million to $130 million. Free cash flow estimates have also been raised to between $1.410 billion and $1.470 billion, signaling strong future growth expectations.

Frequently Asked Questions

What was MSCI's total revenue for the third quarter?

MSCI reported total revenue of $793.4 million for the third quarter, reflecting a 9.5% increase year-over-year.

How much did MSCI's adjusted EPS surpass analyst expectations?

The adjusted earnings per share for MSCI was $4.47, which surpassed the analyst consensus of $4.37.

What is MSCI's total annualized recurring revenue run rate?

As of September 30, 2025, MSCI's total run rate for recurring revenues was $3.19 billion.

What percentage of customer retention did MSCI achieve?

MSCI reported a customer retention rate of 94.7%, indicating stable client loyalty.

What did the new stock repurchase program authorize?

The Board of Directors approved a new stock repurchase program for up to $3.0 billion of MSCI's common stock.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sarwant Singh Propels Frost & Sullivan's AI Ambitions

Updated Category News Views 2

A Veteran Strategist Returns to the Fold Sharp moves in the corporate world don't always grab headlines, but sometimes you’ve got to stop and consider the buzzworthy comebacks. Keep your eyes peeled for Sarwant Singh's return to Frost & Sullivan, a noteworthy shift that’s shaping the landscape of digital strategies and beyond. Turning Up the Heat on Digital Innovation...

Continue Reading
Pathology Ventures: Industry Veteran Takes the Helm

Updated Category News Views 3

What's Brewing with Pathology Ventures? Amidst the bustling landscape of healthcare, Pathology Ventures, LLC shakes things up by appointing Dominic Stockey as their Executive Vice President. Now, buckle up because Stockey isn’t your average Joe. He’s kicking it up a notch by spearheading sponsor and industry partnerships at this physician-founded network. His turf?...

Continue Reading
National Solar Tour 2026: Discover Solar Power Live

Updated Category News Views 0

Experience Real-Life Solar Innovations It's always worth raising an eyebrow when a grassroots event, that's been kicking around for over three decades, rolls around just waving at us to take part. The National Solar Tour 2026 is crash-landing this weekend, October 2-4, like clockwork, bringing solar tech right to your front porch, figuratively and literally speaking. Get...

Continue Reading
Ontario Fuels Life Sciences Growth with $1.7M Boost

Updated Category News Views 4

A Jolt for Ontario's Life Sciences Sector Ah, there's fresh energy in the air up north, folks. Ontario's dishing out a solid $1.7 million to give Piramal Pharma Solutions' Aurora facility a serious facelift. This isn't just about shiny new labs. It's about staking a claim, saying, "We're serious players on the global stage." They're not just upgrading infrastructure...

Continue Reading
Skiptown Expands into Austin: A New Pet Care Frontier

Updated Category News Views 3

Skiptown Marches into the Heart of Texas A move into Texas? Now that's got potential written all over it. Skiptown's making waves by dropping anchor in Austin with a five-unit franchise agreement. We're talking modern dog daycare and more, right in the heart of Central Texas. First up, fall 2027 is when you can circle the calendar. Expect to see more locations sprout up...

Continue Reading
Oak Farms Invests in Texas Schools and Students

Updated Category News Views 4

Putting Money Where Their Roots Are You have to hand it to Oak Farms; when they say they're rooted in Texas, they actually back it up with some cold, hard cash. They've lined up $27,500 for schools and students across the state. That's the kind of talking I like to see—straight from the brand to the community ledger. No fluff, just good old-fashioned giving in the form...

Continue Reading
Virginia's 3D Printing Push: Affordable Housing Revolution

Updated Category News Views 3

Pioneering Affordable Homes with 3D Printing There’s something brewing in Henrico County that’s got the potential to shake up the entire construction industry: 3D printing. Now, hold your horses if you think this isn’t about stock tickers flashing green or red. Sometimes it’s just about reimagining what living affordable means. With Richmond Metropolitan Habitat...

Continue Reading
Kohler's Golf Innovation: No Tees Tour Comes Alive

Updated Category News Views 2

Golf Reinvented: Kohler Hosts No Tees Tour Talk about flipping the script, eh? Kohler's teaming up with the No Tees Tour to host an innovative golfing showdown at The Baths of Blackwolf Run, starting October 1. This isn't your grandpa's golf tour. We're talking fast-paced, head-to-head chipping duels that ditch the long drives for surgical precision. The idea's inspired...

Continue Reading
Fitness Connection Plots New Facility at CityNorth Park

Updated Category News Views 4

Alright, folks, let's talk Fitness Connection and their fresh move that's shaking things up in North Houston. So, they're not just sticking around; they're tuning up a beefy new 45,000-square-foot club right where Greenspoint Mall once stood. There's a $150 million overhaul going on at this site now known as CityNorth, and Fitness Connection plans to be right at the heart...

Continue Reading
Caracal's New Baltimore Hub: A Green Leap in Healthcare

Updated Category News Views 3

Recycling Revolution: Caracal's Bold Move in Baltimore In a world drowning in waste, Caracal Products & Services is making a stand—this time in Baltimore. This latest venture isn't just another warehouse on the map; it’s a beacon for sustainable practices in healthcare recycling. An industrial complex at 2-6 Alco Place now houses Caracal's 9,000-square-foot hub, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploration of the Future of Manual Cutting Equipment

Updated Category News Views 51

Future Projections for the Manual Cutting Equipment Market The manual cutting equipment market is set for substantial growth, with estimates indicating it could reach USD 24.6 billion by 2032. This expansion is primarily fueled by the increasing demand within the construction industry, where efficient and reliable cutting tools are becoming essential. As construction...

Continue Reading
Challenges Faced by Vincerx Pharma as Stock Hits New Low

Updated Category News Views 51

Vincerx Pharma's Stock Plummets to Historic Low In today's unpredictable financial landscape, Vincerx Pharma, Inc. (VINC) has seen its stock plunge to a new 52-week low of $0.51. This decline marks a staggering 1-year change of -42.34%, sending ripples of concern among investors. With the biopharmaceutical sector grappling with various challenges ranging from economic...

Continue Reading
Israel and Hamas to Negotiate Ceasefire and Hostage Release

Updated Category News Views 183

Israel and Hamas Begin Ceasefire Negotiations Israel has unveiled its intentions to negotiate with Hamas, focusing on establishing a durable ceasefire in Gaza and facilitating the release of additional hostages. The atmosphere surrounding this development is critical as both parties aim to chart a path toward peace. Key Developments in the Negotiations Gideon Sa'ar,...

Continue Reading
Recognizing Excellence: 2025 Best Hospitals for Black Health

Updated Category News Views 213

Celebrating Exceptional Care in Black Healthcare In a significant move for the healthcare community, BlackDoctor.org has unveiled the 2025 Best Hospitals for Black America list. This initiative highlights hospitals that are committed to providing outstanding care to Black patients, marking a substantial step forward in addressing healthcare disparities. The selection...

Continue Reading
Marker Therapeutics Advances Off-the-Shelf Cancer Treatment

Updated Category News Views 166

Significant Milestone Achieved in Cancer Treatment Marker Therapeutics, Inc. has made a remarkable advancement in the field of immuno-oncology with the initiation of its Off-the-Shelf (OTS) program. This innovative approach focuses on developing Multi-Antigen Recognizing (MAR) T cells, specifically designed to expedite patient treatment timelines in the rapidly evolving...

Continue Reading